WEST BRIDGEWATER, Mass.--(BUSINESS WIRE)--SeraCare Life Sciences, Inc. (“SRLS”) today announced that it has entered into a three-year Credit and Security Agreement, with Merrill Lynch Capital, a division of Merrill Lynch Business Financial Services, Inc., as a lender and as the Administrative Agent, pursuant to which a $10 million revolving loan facility was made available to the Company. Obligations under the Credit Agreement are secured by substantially all the assets of the Company, excluding the Company’s real property located at its West Bridgewater facility, which is subject to a separate mortgage. The Revolving Loan Facility, which may be used for working capital and other general corporate purposes, is governed by a borrowing base. As of June 11, 2007, the Company has not borrowed any amounts under the Revolving Loan Facility.
